- Report
- July 2025
- 80 Pages
United States
From €5170EUR$5,950USD£4,507GBP
- Report
- January 2026
- 80 Pages
Europe
From €4128EUR$4,750USD£3,598GBP
- Report
- March 2025
- 131 Pages
Europe
From €2998EUR$3,450USD£2,613GBP
- Report
- April 2025
- 163 Pages
Asia Pacific
From €2998EUR$3,450USD£2,613GBP
- Report
- April 2025
- 153 Pages
Africa, Middle East
From €2998EUR$3,450USD£2,613GBP
- Report
- October 2025
- 96 Pages
Middle East
From €4214EUR$4,850USD£3,674GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4214EUR$4,850USD£3,674GBP
- Report
- September 2025
- 99 Pages
United States
From €4214EUR$4,850USD£3,674GBP
- Database
- February 2026
Global
From €261EUR$300USD£227GBP
- Report
- January 2025
- 363 Pages
Global
From €4170EUR$4,799USD£3,635GBP
- Report
- November 2024
- 716 Pages
Global
From €4170EUR$4,799USD£3,635GBP
- Report
- September 2024
- 375 Pages
Global
From €4170EUR$4,799USD£3,635GBP
- Report
- September 2022
- 799 Pages
Global
From €4170EUR$4,799USD£3,635GBP
- Report
- September 2024
- 174 Pages
Global
From €2050EUR$2,527USD£1,850GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,219USD£1,624GBP
- Report
- December 2024
- 342 Pages
Global
From €5165EUR$6,151USD£4,350GBP
- Report
- April 2019
- 850 Pages
Global
From €3909EUR$4,499USD£3,408GBP
- Report
- December 2022
- 437 Pages
Global
From €4690EUR$5,586USD£3,950GBP
- Report
- May 2024
- 224 Pages
Global
From €4170EUR$4,799USD£3,635GBP
- Report
- January 2019
- 230 Pages
Global
From €3475EUR$3,999USD£3,029GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more